Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 292: C564-C572, 2007. First published July 26, 2006; doi:10.1152/ajpcell.00269.2006
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/C564    most recent
00269.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ju, J.-S.
Right arrow Articles by Fisher, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ju, J.-S.
Right arrow Articles by Fisher, J. S.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase

Jeong-Sun Ju, Michael A. Gitcho, Carter A. Casmaer, Pankaj B. Patil, Dae-Gyue Han, Susan A. Spencer, and Jonathan S. Fisher

Department of Biology, Saint Louis University, St. Louis, Missouri

Submitted 16 May 2006 ; accepted in final form 18 July 2006

Data from the use of activators and inhibitors of the AMP-activated protein kinase (AMPK) suggest that AMPK increases sensitivity of glucose transport to stimulation by insulin in muscle cells. We assayed insulin action after adenoviral (Ad) transduction of constitutively active (CA; a truncated form of AMPK{alpha}1) and dominant-negative (DN; which depletes endogenous AMPK{alpha}) forms of AMPK{alpha} (Ad-AMPK{alpha}-CA and Ad-AMPK{alpha}-DN, respectively) into C2C12 myotubes. Compared with control (Ad-green fluorescent protein), Ad-AMPK-CA increased the ability of insulin to stimulate glucose transport. The increased insulin action in cells expressing AMPK-CA was suppressed by compound C (an AMPK inhibitor). Exposure of cells to 5-aminoimidazole-4-carboxamide-1beta-D-ribofuranoside (an AMPK activator) increased insulin action in uninfected myotubes and myotubes transduced with green fluorescent protein but not in Ad-AMPK-DN-infected myotubes. In Ad-AMPK-CA-transduced cells, serine phosphorylation of insulin receptor substrate 1 was decreased at a mammalian target of rapamycin (or p70 S6 kinase) target site that has been reported to be associated with insulin resistance. These data suggest that, in myotubes, activated AMPK{alpha}1 is sufficient to increase insulin action and that the presence of functional AMPK{alpha} is required for 5-aminoimidazole-4-carboxamide-1beta,D-ribofuranoside-related increases in insulin action.

compound C; AMPK; insulin sensitivity; Akt; mTOR



Address for reprint requests and other correspondence: J. S. Fisher, Dept. of Biology, Saint Louis Univ., 3507 Laclede Ave, St. Louis, MO 63103 (e-mail: fisherjs{at}SLU.edu)




This article has been cited by other articles:


Home page
ptjournalHome page
L. P Turcotte and J. S Fisher
Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise
Physical Therapy, November 1, 2008; 88(11): 1279 - 1296.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.